Tracheo-esophageal fistula with bevacizumab after mediastinal radiation

被引：36
作者：
Goodgame, Boone [1 ]
Veeramachaneni, Nirmal [2 ]
Patterson, Alexander [2 ]
Govindan, Ramaswamy [1 ]
机构：
[1] Washington Univ, Sch Med, Div Oncol, St Louis, MO 63021 USA
[2] Washington Univ, Sch Med, Div Cardiothorac Surg, St Louis, MO 63021 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2008年 / 3卷 / 09期
关键词：
D O I：
10.1097/JTO.0b013e3181858eba
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1080 / 1081
页数：2
相关论文
共 6 条
  • [1] [Anonymous], AVASTIN BEVACIZUMAB
  • [2] Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer
    Faivre, S
    Delbaldo, C
    Vera, K
    Robert, C
    Lozahic, S
    Lassau, N
    Bello, C
    Deprimo, S
    Brega, A
    Massimini, G
    Armand, JP
    Scigalla, P
    Raymond, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (01) : 25 - 35
  • [3] Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
    Sandler, Alan
    Gray, Robert
    Perry, Michael C.
    Brahmer, Julie
    Schiller, Joan H.
    Dowlati, Afshin
    Lilenbaum, Rogerio
    Johnson, David H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (24) : 2542 - 2550
  • [4] Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab
    Scappaticci, FA
    Fehrenbacher, L
    Cartwright, T
    Hainsworth, JD
    Heim, W
    Berlin, J
    Kabbinavar, F
    Novotny, W
    Sarkar, S
    Hurwitz, H
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2005, 91 (03) : 173 - 180
  • [5] Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer
    Seiwert, Tanguy Y.
    Haraf, Daniel J.
    Cohen, Ezra E. W.
    Stenson, Kerstin
    Witt, Mary Ellyn
    Dekker, Allison
    Kocherginsky, Masha
    Weichselbaum, Ralph R.
    Chen, Helen X.
    Vokes, Everett E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) : 1732 - 1741
  • [6] 2007, IMPORTANT DRUG WARNI
1